Bristol Myers Squibb ROE 2012-2025 | BMY

Current and historical return on equity (ROE) values for Bristol Myers Squibb (BMY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Bristol Myers Squibb ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-09-30 $6.04B $18.60B 34.55%
2025-06-30 $5.05B $17.49B 29.47%
2025-03-31 $5.42B $17.45B 31.83%
2024-12-31 $-8.95B $16.39B -53.26%
2024-09-30 $-7.26B $17.20B -36.15%
2024-06-30 $-6.54B $17.07B -28.39%
2024-03-31 $-6.15B $16.55B -22.96%
2023-12-31 $8.03B $29.49B 26.21%
2023-09-30 $8.29B $29.06B 26.71%
2023-06-30 $7.96B $32.03B 24.93%
2023-03-31 $7.31B $31.89B 22.78%
2022-12-31 $6.33B $31.12B 19.75%
2022-09-30 $6.68B $32.73B 20.07%
2022-06-30 $6.62B $32.66B 19.24%
2022-03-31 $6.25B $31.65B 17.63%
2021-12-31 $6.99B $36.01B 18.92%
2021-09-30 $-5.41B $37.28B -14.44%
2021-06-30 $-5.08B $36.87B -12.49%
2021-03-31 $-6.22B $37.67B -14.22%
2020-12-31 $-9.02B $37.88B -19.26%
2020-09-30 $-0.04B $50.23B -0.09%
2020-06-30 $-0.56B $49.16B -1.34%
2020-03-31 $0.95B $49.98B 2.81%
2019-12-31 $3.44B $51.70B 13.63%
2019-09-30 $5.66B $17.75B 35.71%
2019-06-30 $6.20B $16.15B 41.81%
2019-03-31 $5.14B $15.32B 37.00%
2018-12-31 $4.92B $14.13B 36.99%
2018-09-30 $1.43B $13.75B 11.25%
2018-06-30 $0.38B $12.42B 2.89%
2018-03-31 $0.92B $12.91B 6.75%
2017-12-31 $1.01B $11.85B 7.18%
2017-09-30 $4.23B $14.91B 27.91%
2017-06-30 $4.59B $14.82B 29.84%
2017-03-31 $4.84B $14.54B 31.33%
2016-12-31 $4.46B $16.35B 28.87%
2016-09-30 $3.37B $15.78B 22.50%
2016-06-30 $2.87B $15.08B 19.35%
2016-03-31 $1.57B $14.55B 10.57%
2015-12-31 $1.57B $14.42B 10.32%
2015-09-30 $1.78B $15.27B 11.59%
2015-06-30 $1.79B $15.29B 11.71%
2015-03-31 $2.25B $15.69B 14.71%
2014-12-31 $2.00B $14.98B 13.12%
2014-09-30 $2.72B $15.20B 17.72%
2014-06-30 $2.69B $15.38B 17.67%
2014-03-31 $2.89B $15.53B 19.32%
2013-12-31 $2.56B $15.24B 17.67%
2013-09-30 $2.76B $14.71B 19.57%
2013-06-30 $1.36B $14.37B 9.77%
2013-03-31 $1.47B $13.70B 10.29%
2012-12-31 $1.96B $13.64B 13.15%
2012-09-30 $1.89B $13.90B 12.20%
2012-06-30 $3.56B $15.81B 22.14%
2012-03-31 $3.82B $16.25B 23.61%
2011-12-31 $3.70B $15.87B 23.01%
2011-09-30 $3.32B $16.44B 20.72%
2011-06-30 $3.30B $16.15B 20.80%
2011-03-31 $3.33B $15.90B 21.16%
2010-12-31 $3.09B $15.64B 19.84%
2010-09-30 $10.63B $15.86B 69.17%
2010-06-30 $10.64B $15.57B 71.00%
2010-03-31 $10.70B $15.23B 73.38%
2009-12-31 $10.59B $14.79B 75.37%
2009-09-30 $3.83B $14.37B 28.57%
2009-06-30 $5.44B $13.94B 41.70%
2009-03-31 $5.22B $13.13B 42.60%
2008-12-31 $5.25B $12.21B 45.15%
2008-09-30 $3.91B $12.94B 34.92%
2008-06-30 $2.19B $10.78B 20.38%
2008-03-31 $2.14B $10.56B 19.85%
2007-12-31 $2.17B $10.56B 20.26%
2007-09-30 $2.12B $11.15B 20.11%
2007-06-30 $1.60B $10.76B 15.02%
2007-03-31 $1.56B $10.26B 14.34%
2006-12-31 $1.59B $9.99B 14.14%
2006-09-30 $2.22B $11.59B 19.26%
2006-06-30 $2.84B $11.71B 24.87%
2006-03-31 $3.18B $11.56B 28.38%
2005-12-31 $3.00B $11.21B 27.49%
2005-09-30 $2.64B $11.27B 24.76%
2005-06-30 $2.43B $10.80B 23.16%
2005-03-31 $1.96B $10.38B 18.78%
2004-12-31 $2.39B $10.20B 22.84%
2004-09-30 $2.76B $10.66B 26.61%
2004-06-30 $2.90B $10.43B 28.45%
2004-03-31 $3.28B $10.53B 32.78%
2003-12-31 $3.11B $9.79B 32.05%
2003-09-30 $3.05B $10.07B 32.28%
2003-06-30 $2.50B $9.61B 27.08%
2003-03-31 $2.07B $9.30B 21.84%
2002-12-31 $2.14B $8.76B 21.70%
2002-09-30 $2.63B $9.20B 26.49%
2002-06-30 $3.46B $10.71B 34.21%
2002-03-31 $4.18B $10.73B 42.58%
2001-12-31 $4.66B $9.08B 49.09%
2001-09-30 $4.89B $9.94B 51.31%
2001-06-30 $4.94B $9.54B 52.91%
2001-03-31 $4.83B $9.44B 52.61%
2000-12-31 $4.71B $9.18B 52.25%
2000-09-30 $4.60B $9.16B 51.79%
2000-06-30 $4.46B $8.92B 51.26%
2000-03-31 $4.32B $8.81B 50.91%
1999-12-31 $4.17B $8.65B 50.67%
1999-09-30 $3.53B $8.44B 44.34%
1999-06-30 $3.40B $8.06B 43.93%
1999-03-31 $3.28B $7.75B 43.56%
1998-12-31 $3.14B $7.58B 42.51%
1998-09-30 $3.53B $7.55B 48.36%
1998-06-30 $3.42B $7.24B 47.86%
1998-03-31 $3.32B $7.19B 47.21%
1997-12-31 $3.21B $7.22B 46.24%
1997-09-30 $3.12B $6.93B 46.08%
1997-06-30 $3.02B $6.82B 45.54%
1997-03-31 $2.93B $6.76B 45.59%
1996-12-31 $2.85B $6.57B 45.75%
1996-09-30 $1.99B $6.35B 32.96%
1996-06-30 $1.93B $6.07B 31.95%
1996-03-31 $1.88B $5.94B 30.98%
1995-12-31 $1.81B $5.82B 29.82%
1995-09-30 $2.05B $6.32B 33.95%
1995-06-30 $1.99B $6.21B 33.04%
1995-03-31 $1.92B $5.96B 32.26%
1994-12-31 $1.84B $5.70B 30.93%
1994-09-30 $2.00B $6.16B 33.24%
1994-06-30 $1.99B $5.97B 32.90%
1994-03-31 $1.97B $6.00B 32.24%
1993-12-31 $1.96B $5.94B 31.96%
1993-09-30 $2.29B $6.25B 37.18%
1993-06-30 $2.27B $6.20B 36.98%
1993-03-31 $2.24B $6.14B 36.84%
1992-12-31 $1.96B $6.02B 32.75%
1992-09-30 $1.89B $6.18B 31.83%
1992-06-30 $1.86B $5.94B 32.04%
1992-03-31 $1.87B $5.83B 32.77%
1991-12-31 $2.06B $5.80B 36.85%
1991-09-30 $1.97B $5.69B 35.95%
1991-06-30 $1.91B $5.45B 35.24%
1991-03-31 $1.83B $5.38B 34.15%
1990-12-31 $1.75B $5.42B 32.87%
1990-06-30 $1.09B $5.28B 22.72%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $122.003B $48.194B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $317.564B 25.28
Amgen (AMGN) United States $197.396B 16.78
Gilead Sciences (GILD) United States $193.298B 19.12
GSK (GSK) United Kingdom $119.226B 12.94
Vertex Pharmaceuticals (VRTX) United States $117.025B 30.13
Regeneron Pharmaceuticals (REGN) United States $81.869B 21.59
CSL (CSLLY) Australia $55.133B 0.00
Argenex SE (ARGX) Netherlands $51.645B 63.80
Alnylam Pharmaceuticals (ALNY) United States $42.578B 1401.22
Insmed (INSM) United States $31.656B 0.00
Biogen (BIIB) United States $28.060B 12.51
Royalty Pharma (RPRX) United States $25.543B 9.16
BioNTech SE (BNTX) Germany $24.630B 0.00
Exact Sciences (EXAS) United States $19.736B 544.37
Incyte (INCY) United States $19.671B 17.07
Genmab (GMAB) Denmark $19.310B 14.52
Revolution Medicines (RVMD) United States $18.943B 0.00
Roivant Sciences (ROIV) United Kingdom $18.639B 0.00
Illumina (ILMN) United States $17.783B 24.00
Moderna (MRNA) United States $15.829B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $14.594B 0.00
Ascendis Pharma (ASND) Denmark $13.727B 0.00
Guardant Health (GH) United States $13.560B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $13.213B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $13.172B 21.26
BioMarin Pharmaceutical (BMRN) United States $11.586B 21.01
Avidity Biosciences (RNA) United States $11.284B 0.00
Exelixis (EXEL) United States $11.152B 15.73
QIAGEN (QGEN) Netherlands $10.783B 20.65
Jazz Pharmaceuticals (JAZZ) Ireland $10.102B 39.39
Bio-Techne Corp (TECH) United States $9.927B 36.05
Abivax SA (ABVX) France $9.631B 0.00
Axsome Therapeutics (AXSM) United States $9.387B 0.00
Halozyme Therapeutics (HALO) United States $9.350B 14.94
Arrowhead Pharmaceuticals (ARWR) United States $8.619B 40.23
Cytokinetics (CYTK) United States $8.167B 0.00
Praxis Precision Medicines (PRAX) United States $8.145B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.959B 28.62
Krystal Biotech (KRYS) United States $7.906B 40.88
Repligen (RGEN) United States $7.847B 83.98
Nuvalent (NUVL) United States $7.500B 0.00
Vaxcyte (PCVX) United States $7.246B 0.00
Cidara Therapeutics (CDTX) United States $6.960B 0.00
Merus (MRUS) Netherlands $6.826B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.572B 0.00
Belite Bio (BLTE) United States $6.567B 0.00
ImmunityBio (IBRX) United States $6.442B 0.00
Kymera Therapeutics (KYMR) United States $5.919B 0.00
Alkermes (ALKS) Ireland $5.764B 16.95
PTC Therapeutics (PTCT) United States $5.694B 7.73
Cogent Biosciences (COGT) United States $5.296B 0.00
Immunovant (IMVT) United States $5.280B 0.00
Protagonist Therapeutics (PTGX) United States $5.219B 134.66
Mirum Pharmaceuticals (MIRM) United States $5.133B 0.00
Celcuity (CELC) United States $4.823B 0.00
Scholar Rock Holding (SRRK) United States $4.809B 0.00
Structure Therapeutics (GPCR) United States $4.610B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.605B 0.00
TG Therapeutics (TGTX) United States $4.575B 10.37
Zealand Pharma (ZLDPF) Denmark $4.534B 4.59
Akero Therapeutics (AKRO) United States $4.499B 0.00
Apogee Therapeutics (APGE) United States $4.496B 0.00
Amicus Therapeutics (FOLD) United States $4.492B 357.75
CG Oncology (CGON) United States $4.320B 0.00
Arcellx (ACLX) United States $4.041B 0.00
GRAIL (GRAL) United States $3.914B 0.00
Anbio Biotechnology (NNNN) Germany $3.908B 0.00
ADMA Biologics Inc (ADMA) United States $3.875B 27.59
ACADIA Pharmaceuticals (ACAD) United States $3.802B 32.10
Ligand Pharmaceuticals (LGND) United States $3.660B 89.84
Erasca (ERAS) United States $3.579B 0.00
Liquidia (LQDA) United States $3.495B 0.00
Terns Pharmaceuticals (TERN) United States $3.481B 0.00
Legend Biotech (LEGN) United States $3.424B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.409B 99.96
Xenon Pharmaceuticals (XENE) Canada $3.304B 0.00
Arcutis Biotherapeutics (ARQT) United States $3.257B 0.00
Edgewise Therapeutics (EWTX) United States $3.246B 0.00
Viking Therapeutics (VKTX) United States $3.227B 0.00
Twist Bioscience (TWST) United States $3.044B 0.00
Denali Therapeutics (DNLI) United States $2.888B 0.00
Viridian Therapeutics (VRDN) United States $2.870B 0.00
Apellis Pharmaceuticals (APLS) United States $2.823B 71.97
IDEAYA Biosciences (IDYA) United States $2.797B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.776B 0.00
Vera Therapeutics (VERA) United States $2.746B 0.00
Disc Medicine (IRON) United States $2.718B 0.00
Travere Therapeutics (TVTX) United States $2.704B 0.00
Alumis (ALMS) United States $2.676B 0.00
Beam Therapeutics (BEAM) United States $2.637B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.636B 0.00
Spyre Therapeutics (SYRE) United States $2.632B 0.00
Immunome (IMNM) United States $2.583B 0.00
Adaptive Biotechnologies (ADPT) United States $2.385B 0.00
Mesoblast (MESO) Australia $2.361B 0.00
Mineralys Therapeutics (MLYS) United States $2.357B 0.00
Bavarian Nordic (BVNRY) Denmark $2.351B 6.38
Telix Pharmaceuticals (TLX) Australia $2.348B 0.00
Arcus Biosciences (RCUS) United States $2.306B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.304B 0.00
Ascentage Pharma Group - (AAPG) China $2.296B 0.00
Maze Therapeutics (MAZE) United States $2.272B 0.00
WAVE Life Sciences (WVE) Singapore $2.219B 0.00
Dianthus Therapeutics (DNTH) United States $2.158B 0.00
Zai Lab (ZLAB) China $2.131B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.107B 11.51
Nuvation Bio (NUVB) United States $1.961B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.929B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.887B 0.00
Sarepta Therapeutics (SRPT) United States $1.882B 0.00
Stoke Therapeutics (STOK) United States $1.840B 48.09
Dynavax Technologies (DVAX) United States $1.819B 53.41
MannKind (MNKD) United States $1.763B 57.40
Vericel (VCEL) United States $1.751B 144.29
Precigen (PGEN) United States $1.737B 0.00
ANI Pharmaceuticals (ANIP) United States $1.713B 13.28
Zymeworks (ZYME) United States $1.709B 0.00
Tango Therapeutics (TNGX) United States $1.698B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.664B 0.00
Nurix Therapeutics (NRIX) United States $1.657B 0.00
Corvus Pharmaceuticals (CRVS) United States $1.654B 0.00
Celldex Therapeutics (CLDX) United States $1.635B 0.00
Sionna Therapeutics (SION) United States $1.630B 0.00
Olema Pharmaceuticals (OLMA) United States $1.624B 0.00
Agios Pharmaceuticals (AGIO) United States $1.616B 0.00
Tyra Biosciences (TYRA) United States $1.601B 0.00
Rapt Therapeutics (RAPT) United States $1.599B 0.00
MBX Biosciences (MBX) United States $1.572B 0.00
AnaptysBio (ANAB) United States $1.530B 0.00
UniQure (QURE) Netherlands $1.502B 0.00
Oculis Holding AG (OCS) Switzerland $1.497B 0.00
NeoGenomics (NEO) United States $1.481B 0.00
Mind Medicine (MindMed) (MNMD) United States $1.480B 0.00
Alvotech (ALVO) Luxembourg $1.462B 21.09
Novavax (NVAX) United States $1.458B 3.71
AtaiBeckley Inc (ATAI) Netherlands $1.442B 0.00
Trevi Therapeutics (TRVI) United States $1.417B 0.00
Intellia Therapeutics (NTLA) United States $1.390B 0.00
Rapport Therapeutics (RAPP) United States $1.317B 0.00
Zenas BioPharma (ZBIO) United States $1.249B 0.00
Biohaven (BHVN) United States $1.247B 0.00
Immatics (IMTX) Germany $1.246B 0.00
Monte Rosa Therapeutics (GLUE) United States $1.235B 59.25
Kodiak Sciences (KOD) United States $1.215B 0.00
Oxford BioMedica (OXBDF) United Kingdom $1.202B 0.00
Inhibrx Biosciences (INBX) United States $1.192B 0.00
Septerna (SEPN) United States $1.179B 0.00
NovoCure (NVCR) Jersey $1.176B 0.00
Nanobiotix S.A - (NBTX) France $1.167B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.153B 0.00
Compass Therapeutics (CMPX) United States $1.145B 0.00
Certara (CERT) United States $1.104B 20.38
Pharming Group (PHAR) Netherlands $1.092B 0.00
Fortrea Holdings (FTRE) United States $1.071B 22.73
EyePoint (EYPT) United States $1.064B 0.00
Sana Biotechnology (SANA) United States $1.034B 0.00
Vir Biotechnology (VIR) United States $1.032B 0.00
Iovance Biotherapeutics (IOVA) United States $1.032B 0.00
Geron (GERN) United States $1.028B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $1.014B 0.00
Ventyx Biosciences (VTYX) United States $1.000B 0.00
Oric Pharmaceuticals (ORIC) United States $0.993B 0.00
Urogen Pharma (URGN) United States $0.990B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.963B 0.00
Castle Biosciences (CSTL) United States $0.944B 129.36
CytomX Therapeutics (CTMX) United States $0.942B 13.90
AbCellera Biologics (ABCL) Canada $0.937B 0.00
Palvella Therapeutics (PVLA) United States $0.937B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.935B 0.00
Pacira BioSciences (PCRX) United States $0.935B 10.70
CureVac (CVAC) Germany $0.927B 0.00
DBV Technologies S.A (DBVT) France $0.908B 0.00
Inventiva S.A (IVA) France $0.903B 0.00
Evommune (EVMN) United States $0.897B 0.00
ArriVent BioPharma (AVBP) United States $0.893B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.873B 0.00
Arvinas (ARVN) United States $0.841B 0.00
Bicara Therapeutics (BCAX) United States $0.811B 0.00
MapLight Therapeutics (MPLT) United States $0.806B 0.00
Arbutus Biopharma (ABUS) United States $0.800B 0.00
Upstream Bio (UPB) United States $0.794B 0.00
Janux Therapeutics (JANX) United States $0.789B 0.00
GH Research (GHRS) Ireland $0.788B 0.00
YD Bio (YDES) $0.779B 0.00
MiMedx (MDXG) United States $0.772B 13.71
Bright Minds Biosciences (DRUG) United States $0.758B 0.00
Gyre Therapeutics (GYRE) United States $0.756B 98.12
Jade Biosciences (JBIO) United States $0.743B 0.00
Astria Therapeutics (ATXS) United States $0.718B 0.00
BioAge Labs (BIOA) United States $0.717B 0.00
Cullinan Therapeutics (CGEM) United States $0.707B 0.00
Kura Oncology (KURA) United States $0.682B 0.00
EnGene Holdings (ENGN) Canada $0.664B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Replimune (REPL) United States $0.641B 0.00
Annexon (ANNX) United States $0.627B 0.00
Prime Medicine (PRME) United States $0.623B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.609B 0.00
MeiraGTx Holdings (MGTX) United States $0.600B 0.00
Design Therapeutics (DSGN) United States $0.590B 0.00
Fulcrum Therapeutics (FULC) United States $0.588B 0.00
CorMedix Inc (CRMD) United States $0.585B 5.42
Emergent Biosolutions (EBS) United States $0.579B 5.57
Ginkgo Bioworks Holdings (DNA) United States $0.567B 0.00
Cytek Biosciences (CTKB) United States $0.557B 0.00
Gossamer Bio (GOSS) United States $0.544B 0.00
SELLAS Life Sciences (SLS) United States $0.523B 0.00
Keros Therapeutics (KROS) United States $0.519B 11.06
Alto Neuroscience (ANRO) United States $0.519B 0.00
Neumora Therapeutics (NMRA) United States $0.501B 0.00
Solid Biosciences (SLDB) United States $0.499B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.498B 0.00
Kamada (KMDA) Israel $0.489B 23.64
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Prothena (PRTA) Ireland $0.481B 0.00
Myriad Genetics (MYGN) United States $0.452B 0.00
Contineum Therapeutics (CTNM) United States $0.445B 0.00
Ocugen (OCGN) United States $0.440B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.439B 0.00
DiaMedica Therapeutics (DMAC) United States $0.432B 0.00
Eton Pharmaceuticals (ETON) United States $0.430B 0.00
REGENXBIO (RGNX) United States $0.430B 0.00
Verastem (VSTM) United States $0.423B 0.00
Entrada Therapeutics (TRDA) United States $0.423B 0.00
LENZ Therapeutics (LENZ) United States $0.423B 0.00
PureTech Health (PRTC) United States $0.422B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.414B 0.00
Tectonic Therapeutic (TECX) United States $0.412B 0.00
Northwest Biotherapeutics (NWBO) United States $0.411B 0.00
Prima BioMed (IMMP) Australia $0.411B 0.00
Niagen Bioscience (NAGE) United States $0.408B 31.94
Zura Bio (ZURA) United States $0.407B 0.00
GENFIT S.A (GNFTY) France $0.400B 0.00
Benitec Biopharma (BNTC) United States $0.399B 0.00
Monopar Therapeutics (MNPR) United States $0.397B 0.00
PepGen (PEPG) United States $0.394B 0.00
Absci (ABSI) United States $0.391B 0.00
NovaBridge Biosciences (NBP) United States $0.391B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.384B 0.00
Greenwich LifeSciences (GLSI) United States $0.384B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.381B 0.00
Climb Bio (CLYM) United States $0.379B 0.00
Invivyd (IVVD) United States $0.375B 0.00
Forte Biosciences (FBRX) United States $0.374B 0.00
Allogene Therapeutics (ALLO) United States $0.371B 0.00
Immix Biopharma (IMMX) United States $0.362B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.360B 0.00
Anavex Life Sciences (AVXL) United States $0.360B 0.00
Aura Biosciences (AURA) United States $0.357B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.351B 0.00
Atea Pharmaceuticals (AVIR) United States $0.348B 0.00
Adlai Nortye (ANL) Cayman Islands $0.343B 0.00
Puma Biotechnology (PBYI) United States $0.335B 8.97
Kyverna Therapeutics (KYTX) United States $0.331B 0.00
Immuneering (IMRX) United States $0.326B 0.00
Amarin (AMRN) Ireland $0.314B 0.00
Rezolute (RZLT) United States $0.312B 0.00
Foghorn Therapeutics (FHTX) United States $0.307B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.305B 0.00
AC Immune (ACIU) Switzerland $0.304B 0.00
Candel Therapeutics (CADL) United States $0.304B 0.00
X4 Pharmaceuticals (XFOR) United States $0.300B 0.00
XOMA Royalty (XOMA) United States $0.288B 0.00
Aardvark Therapeutics (AARD) United States $0.276B 0.00
Abeona Therapeutics (ABEO) United States $0.274B 4.48
Nautilus Biotechnology (NAUT) United States $0.273B 0.00
Lifecore Biomedical (LFCR) United States $0.271B 0.00
Adherex Technologies (FENC) United States $0.268B 0.00
Neurogene (NGNE) United States $0.262B 0.00
Palisade Bio (PALI) United States $0.259B 0.00
Shattuck Labs (STTK) United States $0.259B 0.00
Cabaletta Bio (CABA) United States $0.247B 0.00
Coherus Oncology (CHRS) United States $0.247B 0.00
Adocia (ADOCY) France $0.231B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.229B 0.00
Opus Genetics (IRD) United States $0.227B 0.00
Nuvectis Pharma (NVCT) United States $0.225B 0.00
CAMP4 Therapeutics (CAMP) United States $0.219B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.210B 0.00
Alector (ALEC) United States $0.210B 0.00
Voyager Therapeutics (VYGR) United States $0.203B 0.00
SAB Biotherapeutics (SABS) United States $0.199B 0.00
Humacyte (HUMA) United States $0.189B 0.00
Molecular Partners AG (MOLN) Switzerland $0.188B 0.00
Kalaris Therapeutics (KLRS) United States $0.180B 0.00
Satellos Bioscience (MSLE) Canada $0.180B 0.00
C4 Therapeutics (CCCC) United States $0.177B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.177B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.176B 0.00
Editas Medicine (EDIT) United States $0.173B 0.00
Sagimet Biosciences (SGMT) United States $0.171B 0.00
Cartesian Therapeutics (RNAC) United States $0.166B 0.00
Tharimmune (THAR) United States $0.164B 0.00
Innate Pharma S.A (IPHA) France $0.159B 0.00
Rani Therapeutics Holdings (RANI) United States $0.157B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.155B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.155B 0.00
Alps Group (ALPS) United States $0.155B 2.82
Connect Biopharma Holdings (CNTB) United States $0.150B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.149B 0.00
Starpharma Holdings (SPHRY) Australia $0.149B 0.00
Caribou Biosciences (CRBU) United States $0.149B 0.00
Anika Therapeutics (ANIK) United States $0.148B 0.00
Elicio Therapeutics (ELTX) United States $0.147B 0.00
Adagene (ADAG) China $0.146B 0.00
Mersana Therapeutics (MRSN) United States $0.145B 0.00
Nkarta (NKTX) United States $0.142B 0.00
Vor Biopharma (VOR) $0.139B 0.00
VTv Therapeutics (VTVT) United States $0.135B 0.00
Fate Therapeutics (FATE) United States $0.135B 0.00
ALX Oncology Holdings (ALXO) United States $0.134B 0.00
Sutro Biopharma (STRO) United States $0.134B 0.00
Spero Therapeutics (SPRO) United States $0.134B 0.00
Whitehawk Therapeutics (WHWK) United States $0.133B 0.00
Sangamo Therapeutics (SGMO) United States $0.132B 0.00
Crescent Biopharma (CBIO) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.127B 0.00
Black Diamond Therapeutics (BDTX) United States $0.126B 6.17
Eledon Pharmaceuticals (ELDN) United States $0.121B 0.00
BGM Group (BGM) China $0.115B 0.00
Repare Therapeutics (RPTX) Canada $0.114B 0.00
Fortress Biotech (FBIO) United States $0.114B 0.00
Alpha Cognition (ACOG) Canada $0.113B 0.00
Ovid Therapeutics (OVID) United States $0.113B 0.00
Tenaya Therapeutics (TNYA) United States $0.113B 0.00
Alpha Teknova (TKNO) United States $0.113B 0.00
Jyong Biotech (MENS) Taiwan $0.111B 0.00
Cardiff Oncology (CRDF) United States $0.108B 0.00
Codexis (CDXS) United States $0.107B 0.00
Inovio Pharmaceuticals (INO) United States $0.107B 0.00
Seer (SEER) United States $0.107B 0.00
Turn Therapeutics (TTRX) United States $0.106B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
Agenus (AGEN) United States $0.101B 0.00
Citius Oncology (CTOR) United States $0.100B 0.00
Actuate Therapeutics (ACTU) United States $0.098B 0.00
Cognition Therapeutics (CGTX) United States $0.097B 0.00
Chrome Holding (MEHCQ) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Artiva Biotherapeutics (ARTV) United States $0.095B 0.00
Equillium (EQ) United States $0.094B 0.00
Precision BioSciences (DTIL) United States $0.093B 0.00
Biomea Fusion (BMEA) United States $0.093B 0.00
BioStem Technologies (BSEM) $0.093B 6.47
Genelux (GNLX) United States $0.092B 0.00
ATyr Pharma (ATYR) United States $0.091B 0.00
Oncolytics Biotech (ONCY) Canada $0.091B 0.00
Immunic (IMUX) United States $0.089B 0.00
Spruce Biosciences (SPRB) United States $0.089B 0.00
EXoZymes (EXOZ) United States $0.084B 0.00
Tenax Therapeutics (TENX) United States $0.081B 0.00
BioHarvest Sciences (BHST) Canada $0.080B 0.00
ImageneBio (IMA) United States $0.079B 0.00
TuHURA Biosciences (HURA) United States $0.078B 0.00
MediciNova (MNOV) United States $0.078B 0.00
MaxCyte (MXCT) United States $0.078B 0.00
IBio (IBIO) United States $0.076B 0.00
Entera Bio (ENTX) Israel $0.075B 0.00
OKYO Pharma (OKYO) $0.073B 0.00
Scilex Holding (SCLX) United States $0.073B 0.00
XBiotech (XBIT) United States $0.072B 0.00
Pliant Therapeutics (PLRX) United States $0.071B 0.00
Adicet Bio (ACET) United States $0.065B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.064B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.063B 0.00
Annovis Bio (ANVS) United States $0.063B 0.00
Radiopharm Theranostics - (RADX) Australia $0.060B 0.00
BeyondSpring (BYSI) United States $0.057B 0.00
InflaRx (IFRX) Germany $0.057B 0.00
Grace Therapeutics (GRCE) United States $0.056B 0.00
TScan Therapeutics (TCRX) United States $0.055B 0.00
Instil Bio (TIL) United States $0.053B 0.00
MiNK Therapeutics (INKT) United States $0.052B 0.00
Tevogen Bio Holdings (TVGN) United States $0.051B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.049B 0.00
Estrella Immunopharma (ESLA) United States $0.049B 0.00
Cingulate (CING) United States $0.049B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.046B 0.00
Aligos Therapeutics (ALGS) United States $0.046B 0.00
Clene (CLNN) United States $0.045B 0.00
CervoMed (CRVO) United States $0.044B 0.00
ABVC BioPharma (ABVC) United States $0.044B 0.00
NextCure (NXTC) United States $0.044B 0.00
Q32 Bio (QTTB) United States $0.043B 0.00
INmune Bio (INMB) United States $0.042B 0.00
Lisata Therapeutics (LSTA) United States $0.040B 0.00
Elutia (ELUT) United States $0.038B 0.00
Generation Bio (GBIO) United States $0.038B 0.00
Pluri (PLUR) Israel $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Celularity (CELU) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.036B 0.00
Tvardi Therapeutics (TVRD) United States $0.035B 0.00
BioXcel Therapeutics (BTAI) United States $0.035B 0.00
PDS Biotechnology (PDSB) United States $0.035B 0.00
Galecto (GLTO) Denmark $0.035B 0.00
Jasper Therapeutics (JSPR) United States $0.035B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Quince Therapeutics (QNCX) United States $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.033B 0.00
TELA Bio (TELA) United States $0.033B 0.00
Atara Biotherapeutics (ATRA) United States $0.033B 2.11
Hyperion DeFi (HYPD) United States $0.033B 0.00
Werewolf Therapeutics (HOWL) United States $0.033B 0.00
Lantern Pharma (LTRN) United States $0.032B 0.00
Kyntra Bio Inc (KYNB) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
BRIACELL THERAP (BCTX) Canada $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Passage Bio (PASG) United States $0.028B 0.00
Exicure (XCUR) United States $0.027B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.027B 0.00
Athira Pharma (ATHA) United States $0.027B 0.00
IO Biotech (IOBT) Denmark $0.026B 0.00
Cue Biopharma (CUE) United States $0.025B 0.00
Rallybio (RLYB) United States $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Aytu BioPharma (AYTU) United States $0.024B 0.00
Medicus Pharma (MDCX) United States $0.024B 0.00
Skye Bioscience (SKYE) United States $0.023B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.023B 0.00
Senti Biosciences (SNTI) United States $0.023B 0.00
VistaGen Therapeutics (VTGN) United States $0.023B 0.00
Intensity Therapeutics (INTS) United States $0.022B 0.00
Apollomics (APLM) United States $0.022B 0.00
Neuphoria Therapeutics (NEUP) United States $0.022B 0.00
LeonaBio (LONA) United States $0.020B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.020B 0.00
IN8bio (INAB) United States $0.019B 0.00
Pasithea Therapeutics (KTTA) United States $0.017B 0.00
FibroBiologics (FBLG) United States $0.017B 0.00
Genenta Science S.p.A (GNTA) Italy $0.017B 0.00
Black Titan (BTTC) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Quantum Biopharma (QNTM) Canada $0.015B 0.00
Curis (CRIS) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
Hoth Therapeutics (HOTH) United States $0.014B 0.00
Applied Therapeutics (APLT) United States $0.014B 0.00
Polyrizon (PLRZ) Israel $0.013B 0.00
Cadrenal Therapeutics (CVKD) United States $0.013B 0.00
Cocrystal Pharma (COCP) United States $0.013B 0.00
NewcelX (NCEL) Switzerland $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
BioAtla (BCAB) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Longeveron (LGVN) United States $0.012B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Soligenix (SNGX) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Revelation Biosciences (REVB) United States $0.010B 0.00
CalciMedica (CALC) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Edesa Biotech (EDSA) Canada $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Beyond Air (XAIR) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Purple Biotech (PPBT) Israel $0.008B 0.00
Gelteq (GELS) Australia $0.007B 0.00
Dogwood Therapeutics (DWTX) United States $0.007B 0.00
Aptevo Therapeutics (APVO) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Evogene (EVGN) Israel $0.005B 0.00
Advanced Biomed (ADVB) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Decoy Therapeutics Inc (DCOY) United States $0.005B 0.00
BioAffinity Technologies (BIAF) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Aprea Therapeutics (APRE) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
KALA BIO (KALA) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Biorestorative Therapies (BRTX) United States $0.004B 0.00
MetaVia (MTVA) United States $0.004B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.004B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Abpro Holdings (ABP) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
HCW Biologics (HCWB) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Arcadia Biosciences (RKDA) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.001B 0.00
Enveric Biosciences (ENVB) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Compugen (CGEN) Israel $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00